About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

To Fight Atherosclerosis, Scientists Search For An Early Biomarker

by Bidita Debnath on May 14, 2013 at 10:37 PM
Font : A-A+

 To Fight Atherosclerosis, Scientists Search For An Early Biomarker

The Journal of the American Heart Association published the conclusive results from a study directed by Dr. Éric Thorin of the Montreal Heart Institute (MHI).

For the first time the study suggests that a blood protein contributes to the early development of atherosclerosis.

Advertisement

Dr. Thorin, his team and his collaborators discovered that the blood levels of angiopoietin-like protein 2 (angptl2) are six times higher in subjects with coronary heart disease than in healthy subjects of the same age. Their basic research study also revealed that angptl2, which is undetectable in young mice, increases with age in healthy subjects and increases prematurely in subjects who have high cholesterol and pre-atherosclerotic lesions. Entitled "Angiopoietin-like 2 promotes atherogenesis in mice," this study was conducted using an animal model consisting of three to twelve-month-old mice.

These results represent a major advance in the prevention and treatment of atherosclerosis. "Although much work remains to be done to broaden our knowledge of this protein's mechanisms of action, angiopoietin-like protein 2 may represent an early biomarker not only to prevent vascular damage but also to predict atherosclerotic disease," explained Dr. Thorin.
Advertisement

For 15 years, Dr. Thorin, a researcher at the MHI Research Centre and full professor at Université de Montréal, has been interested in the evolution of artery function during the aging process and in the underlying mechanisms of atherosclerosis. More specifically over the past five years, he has looked at the role of this particular protein. Thanks to his work, we now know that angptl2 causes a high degree of vascular inflammation. Blood levels of this protein increase in patients with cardiovascular disease as well as in people with complications related to diabetes, obesity and cancer in which the small blood vessels are damaged, as all of these diseases are associated with chronic inflammation.

According to Dr. Anil Nigam, a cardiologist and specialist in cardiovascular disease prevention at the MHI and co-author of the study, "Prevention is the ideal solution to delay the onset of atherosclerosis, and an early blood marker such as angptl2—if future clinical studies confirm this finding—will serve as an important tool to identify at-risk subjects who do not present with any symptoms of atherosclerotic disease."

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Contraceptive Pills in Polycystic Ovary Syndrome (PCOS) Curtail Type 2 Diabetes Risk
Mushroom May Help Cut Down the Odds of Developing Depression
How to Battle Boredom during COVID
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Atherosclerosis 

Recommended Reading
VEGF may Not be Relevant Biomarker in Advanced Prostate Cancer Patients
The well-studied protein VEGF does not appear to have any prognostic or predictive value for men ......
New Biomarker for Pregnancy-associated Heart Disease Identified
University of Liege in Liege, Belgium have discovered miR-146a a new molecule that can serve as a .....
In Early Preterm Infants, Biomarker for Devastating Intestinal Disease Found
A biomarker is being discovered by researchers that may help prevent a devastating intestinal ......
Scientists Identify Biomarkers That May Predict Response to Drugs Targeting KRAS-Mutated NSCLC
Biomarkers have been identified by scientists that may help predict whether patients with ......
Atherosclerosis
Atherosclerosis is a condition in which the arteries become hard and narrow, leading to restricted b...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use